← SynDRA
CC-401
SynDRA canonical compound SYN0025687 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MAPK8 |
|---|
| Mechanism of action | JNK inhibitor |
|---|
All known targets
- MAPK8
- MAPK10
- MAPK8; MAPK9; MAPK10
- MAPK9
- MELK
Mechanisms of action (all sources)
- MAPK8 INHIBITOR
- c-Jun N-terminal kinase 1 inhibitor
- MAPK9 INHIBITOR
- c-Jun N-terminal kinase 2 inhibitor
- MAPK10 INHIBITOR
- c-Jun N-terminal kinase 3 inhibitor
- MELK INHIBITOR
- Modulator
Cross-references
Synonyms
- CC 401
- UNII-NOE38VQA1W
- NOE38VQA1W
- 3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole
- 3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-3-yl)-1H-indazole
- 3-[3-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-5-(1H-1,2,4-TRIAZOL-5-YL)-1H-INDAZOLE
- C22H24N6O
- PubChem22434
- SCHEMBL4604749
- CHEMBL1614713
- CHEBI:91437
- DTXSID40192650
- MolPort-044-561-531
- MolPort-021-804-942
- BCPP000298
- BCP01960
- ZINC38836256
- RS0046
- HY-13022A
- AKOS027251057
- AKOS027336636
- DB12432
- BCP9000495
- CS-1955
- CC401
- CC401 cpd
- RefChem:124080
- JNK Inhibitor CC-401
- DTXCID80115141
- orb1704635
- SCHEMBL4607855
- SCHEMBL29357538
- SCHEMBL30290855
- EX-A3583A
- GTPL11457
- HMS3672K03
- BDBM50248942
- NSC800068
Look up CC-401 in the interactive SynDRA portal →